Skip to Content

Alefacept

In the US, Alefacept (alefacept systemic) is a member of the drug class selective immunosuppressants and is used to treat Plaque Psoriasis and Psoriasis.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L04AA15

CAS registry number (Chemical Abstracts Service)

0222535-22-0

Chemical Formula

C3264-H5002-N840-O988-S20

Molecular Weight

72740

Therapeutic Categories

Selective immunosuppressant

Antipsoriatic

Chemical Name

1-92-antigen LFA-3 (human) fusion protein wit human immunoglobulin G1 (hinge-CH2-CH3 gamma1-chain), dimer (WHO)

Foreign Names

  • Alefaceptum (Latin)
  • Alefacept (German)
  • AlĂ©facept (French)
  • Alefacept (Spanish)

Generic Names

  • Alefacept (OS: USAN, BAN)
  • BG 9273 (IS: Biogen)
  • BG 9712 (IS: Biogen)
  • Human LFA 3IgG fusion protein (IS)
  • Leukocyte function-associated antigen-3 (IS)
  • LFA 3 (IS)
  • LFA 3CD2 (IS)
  • LFA 3TIP (IS: Biogen)
  • LFA-(92)IgG (IS)
  • Recombinant LFA-3/IgG1 fusion protein (IS)

Brand Name

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide